Friedreich Ataxia Drug Market Status and Trend Analysis 2017-2026 (COVID-19 Version) | Analytical Research Cognizance

Friedreich Ataxia Drug Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Published by ARCNS001
Report ID 1513886
Published date Nov 24, 2020
Category Pharmaceuticals and Healthcare
Total Pages 109
Choose license type Buy Now
Request a Sample Enquiry Before Buying Check Discount

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Friedreich Ataxia Drug market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Friedreich Ataxia Drug market segmented into
ADVM-063
AGIL-FA
BHV-4157
BVA-202
Others

Based on the end-use, the global Friedreich Ataxia Drug market classified into
Clinic
Hospital
Others

Based on geography, the global Friedreich Ataxia Drug market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Adverum Biotechnologies Inc
BioMarin Pharmaceutical Inc.
Biovista Inc.
Cardero Therapeutics Inc
Catabasis Pharmaceuticals, Inc.
Forward Pharma A/S
Ixchel Pharma LLC
Pfizer Inc
ProQR Therapeutics NV
RaNA Therapeutics Inc
Reata Pharmaceuticals Inc
Retrotope Inc
Shire Plc
STATegics Inc
Voyager Therapeutics Inc

Chapter One: RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL FRIEDREICH ATAXIA DRUG INDUSTRY
2.1 Summary about Friedreich Ataxia Drug Industry
2.2 Friedreich Ataxia Drug Market Trends
2.2.1 Friedreich Ataxia Drug Production & Consumption Trends
2.2.2 Friedreich Ataxia Drug Demand Structure Trends
2.3 Friedreich Ataxia Drug Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 ADVM-063
4.2.2 AGIL-FA
4.2.3 BHV-4157
4.2.4 BVA-202
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Clinic
4.3.2 Hospital
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 ADVM-063
5.2.2 AGIL-FA
5.2.3 BHV-4157
5.2.4 BVA-202
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Clinic
5.3.2 Hospital
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 ADVM-063
6.2.2 AGIL-FA
6.2.3 BHV-4157
6.2.4 BVA-202
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Clinic
6.3.2 Hospital
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 ADVM-063
7.2.2 AGIL-FA
7.2.3 BHV-4157
7.2.4 BVA-202
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Clinic
7.3.2 Hospital
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 ADVM-063
8.2.2 AGIL-FA
8.2.3 BHV-4157
8.2.4 BVA-202
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Clinic
8.3.2 Hospital
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 ADVM-063
9.2.2 AGIL-FA
9.2.3 BHV-4157
9.2.4 BVA-202
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Clinic
9.3.2 Hospital
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Adverum Biotechnologies Inc
10.1.2 BioMarin Pharmaceutical Inc.
10.1.3 Biovista Inc.
10.1.4 Cardero Therapeutics Inc
10.1.5 Catabasis Pharmaceuticals, Inc.
10.1.6 Forward Pharma A/S
10.1.7 Ixchel Pharma LLC
10.1.8 Pfizer Inc
10.1.9 ProQR Therapeutics NV
10.1.10 RaNA Therapeutics Inc
10.1.11 Reata Pharmaceuticals Inc
10.1.12 Retrotope Inc
10.1.13 Shire Plc
10.1.14 STATegics Inc
10.1.15 Voyager Therapeutics Inc
10.2 Friedreich Ataxia Drug Sales Date of Major Players (2017-2020e)
10.2.1 Adverum Biotechnologies Inc
10.2.2 BioMarin Pharmaceutical Inc.
10.2.3 Biovista Inc.
10.2.4 Cardero Therapeutics Inc
10.2.5 Catabasis Pharmaceuticals, Inc.
10.2.6 Forward Pharma A/S
10.2.7 Ixchel Pharma LLC
10.2.8 Pfizer Inc
10.2.9 ProQR Therapeutics NV
10.2.10 RaNA Therapeutics Inc
10.2.11 Reata Pharmaceuticals Inc
10.2.12 Retrotope Inc
10.2.13 Shire Plc
10.2.14 STATegics Inc
10.2.15 Voyager Therapeutics Inc
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Table
1.Table Friedreich Ataxia Drug Product Type Overview
2.Table Friedreich Ataxia Drug Product Type Market Share List
3.Table Friedreich Ataxia Drug Product Type of Major Players
4.Table Brief Introduction of Adverum Biotechnologies Inc
5.Table Brief Introduction of BioMarin Pharmaceutical Inc.
6.Table Brief Introduction of Biovista Inc.
7.Table Brief Introduction of Cardero Therapeutics Inc
8.Table Brief Introduction of Catabasis Pharmaceuticals, Inc.
9.Table Brief Introduction of Forward Pharma A/S
10.Table Brief Introduction of Ixchel Pharma LLC
11.Table Brief Introduction of Pfizer Inc
12.Table Brief Introduction of ProQR Therapeutics NV
13.Table Brief Introduction of RaNA Therapeutics Inc
14.Table Brief Introduction of Reata Pharmaceuticals Inc
15.Table Brief Introduction of Retrotope Inc
16.Table Brief Introduction of Shire Plc
17.Table Brief Introduction of STATegics Inc
18.Table Brief Introduction of Voyager Therapeutics Inc
19.Table Products & Services of Adverum Biotechnologies Inc
20.Table Products & Services of BioMarin Pharmaceutical Inc.
21.Table Products & Services of Biovista Inc.
22.Table Products & Services of Cardero Therapeutics Inc
23.Table Products & Services of Catabasis Pharmaceuticals, Inc.
24.Table Products & Services of Forward Pharma A/S
25.Table Products & Services of Ixchel Pharma LLC
26.Table Products & Services of Pfizer Inc
27.Table Products & Services of ProQR Therapeutics NV
28.Table Products & Services of RaNA Therapeutics Inc
29.Table Products & Services of Reata Pharmaceuticals Inc
30.Table Products & Services of Retrotope Inc
31.Table Products & Services of Shire Plc
32.Table Products & Services of STATegics Inc
33.Table Products & Services of Voyager Therapeutics Inc
34.Table Market Distribution of Major Players
35.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
36.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
37.Table Global Friedreich Ataxia Drug Market Forecast (Million USD) by Region 2021f-2026f
38.Table Global Friedreich Ataxia Drug Market Forecast (Million USD) Share by Region 2021f-2026f
39.Table Global Friedreich Ataxia Drug Market Forecast (Million USD) by Demand 2021f-2026f
40.Table Global Friedreich Ataxia Drug Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Friedreich Ataxia Drug Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Friedreich Ataxia Drug Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Friedreich Ataxia Drug Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Friedreich Ataxia Drug Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Friedreich Ataxia Drug Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Friedreich Ataxia Drug Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Friedreich Ataxia Drug Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure ADVM-063 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure AGIL-FA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure BHV-4157 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure BVA-202 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure ADVM-063 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure AGIL-FA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure BHV-4157 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure BVA-202 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure ADVM-063 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure AGIL-FA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure BHV-4157 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure BVA-202 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure ADVM-063 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure AGIL-FA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure BHV-4157 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure BVA-202 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure ADVM-063 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure AGIL-FA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure BHV-4157 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure BVA-202 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
74.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
75.Figure ADVM-063 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
76.Figure AGIL-FA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Gro